共有 50 笔近期内部人交易记录记录，涉及 CymaBay Therapeutics, Inc. (CBAY), 包括 11 笔买入 和 39 笔卖出. 内部人买入总额为 $1.92M 内部人卖出总额为 $21.25M.
近期活跃的重要内部人包括 Wiggans Thomas G, Emster Kurt Von, Quinlan Paul T. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CBAY
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-03-22 |
Wiggans Thomas G |
Director |
股份退回 |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Emster Kurt Von |
Director |
股份退回 |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Quinlan Paul T |
General Counsel |
股份退回 |
105,625 |
$22.85 |
$2.41M |
- |
| 2024-03-22 |
Dickinson Klara |
Chief Regulatory Officer |
股份退回 |
78,000 |
$22.85 |
$1.78M |
- |
| 2024-03-22 |
Loewy Caroline M |
Director |
股份退回 |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Shah Sujal |
Chief Executive Officer |
股份退回 |
357,500 |
$22.85 |
$8.17M |
- |
| 2024-03-22 |
Mcwherter Charles |
President of R&d |
股份退回 |
118,625 |
$22.85 |
$2.71M |
- |
| 2024-03-22 |
Lefebvre Eric |
Director |
股份退回 |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Wills Robert James |
Director |
股份退回 |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Dorling Janet |
Director |
股份退回 |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Shantharam Harish |
Chief Financial Officer |
股份退回 |
74,750 |
$22.85 |
$1.71M |
- |
| 2024-03-13 |
Quinlan Paul T |
General Counsel |
期权行权（卖出） |
41,824 |
$7.89 |
$329.99K |
8,872 |
| 2024-03-13 |
Shah Sujal |
Chief Executive Officer |
期权行权（卖出） |
14,625 |
$1.06 |
$15.5K |
- |
| 2024-02-12 |
Dorling Janet |
Director |
知情卖出 |
6,000 |
$31.97 |
$191.85K |
- |
| 2024-01-24 |
Wiggans Thomas G |
Director |
限制性股票授予 (RSU) |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Emster Kurt Von |
Director |
限制性股票授予 (RSU) |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Quinlan Paul T |
General Counsel |
限制性股票授予 (RSU) |
28,438 |
- |
- |
28,438 |
| 2024-01-24 |
Dickinson Klara |
Chief Regulatory Officer |
限制性股票授予 (RSU) |
21,000 |
- |
- |
21,000 |
| 2024-01-24 |
Loewy Caroline M |
Director |
限制性股票授予 (RSU) |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Shah Sujal |
Chief Executive Officer |
限制性股票授予 (RSU) |
96,250 |
- |
- |
267,551 |
| 2024-01-24 |
Mcwherter Charles |
President of R&d |
限制性股票授予 (RSU) |
31,938 |
- |
- |
46,938 |
| 2024-01-24 |
Lefebvre Eric |
Director |
限制性股票授予 (RSU) |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Wills Robert James |
Director |
限制性股票授予 (RSU) |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Dorling Janet |
Director |
限制性股票授予 (RSU) |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Shantharam Harish |
Chief Financial Officer |
限制性股票授予 (RSU) |
20,125 |
- |
- |
20,125 |
| 2024-01-19 |
Mcwherter Charles |
President of R&d |
知情卖出 |
2,250 |
$23.67 |
$53.26K |
15,000 |
| 2024-01-16 |
Quinlan Paul T |
General Counsel |
知情卖出 |
5,000 |
$23.58 |
$117.9K |
- |
| 2024-01-16 |
Menold Daniel |
Vice President, Finance |
知情卖出 |
10,000 |
$23.58 |
$235.81K |
- |
| 2024-01-10 |
Dorling Janet |
Director |
知情卖出 |
6,000 |
$23.86 |
$143.14K |
- |
| 2023-12-18 |
Mcwherter Charles |
President of R&d |
期权行权（卖出） |
6,504 |
$5.00 |
$32.52K |
- |
| 2023-12-15 |
Quinlan Paul T |
General Counsel |
知情卖出 |
5,000 |
$21.98 |
$109.9K |
- |
| 2023-12-15 |
Menold Daniel |
Vice President, Finance |
知情卖出 |
10,000 |
$21.98 |
$219.85K |
- |
| 2023-12-11 |
Shah Sujal |
Chief Executive Officer |
期权行权（卖出） |
12,973 |
$5.00 |
$64.87K |
- |
| 2023-12-11 |
Dorling Janet |
Director |
知情卖出 |
6,000 |
$20.07 |
$120.42K |
- |
| 2023-11-17 |
Mcwherter Charles |
President of R&d |
期权行权（卖出） |
236 |
$5.00 |
$1.18K |
234 |
| 2023-11-15 |
Quinlan Paul T |
General Counsel |
知情卖出 |
5,000 |
$17.38 |
$86.89K |
- |
| 2023-11-15 |
Menold Daniel |
Vice President, Finance |
知情卖出 |
- |
$17.38 |
- |
- |
| 2023-11-13 |
Shah Sujal |
Chief Executive Officer |
期权行权（卖出） |
12,972 |
$5.00 |
$64.86K |
12,973 |
| 2023-11-10 |
Dorling Janet |
Director |
知情卖出 |
7,000 |
$15.24 |
$106.7K |
- |
| 2023-10-18 |
Mcwherter Charles |
President of R&d |
期权行权（卖出） |
10,401 |
$5.00 |
$52.01K |
- |
| 2023-10-16 |
Quinlan Paul T |
General Counsel |
知情卖出 |
5,000 |
$13.76 |
$68.8K |
- |
| 2023-10-16 |
Menold Daniel |
Vice President, Finance |
知情卖出 |
- |
$13.76 |
- |
- |
| 2023-10-09 |
Shah Sujal |
Chief Executive Officer |
期权行权（卖出） |
12,972 |
$5.00 |
$64.86K |
25,945 |
| 2023-09-29 |
Emster Kurt Von |
Director |
期权行权（卖出） |
5,249 |
$5.00 |
$26.25K |
- |
| 2023-09-18 |
Mcwherter Charles |
President of R&d |
期权行权（卖出） |
236 |
$5.00 |
$1.18K |
706 |
| 2023-09-15 |
Quinlan Paul T |
General Counsel |
知情卖出 |
24,000 |
$16.87 |
$404.92K |
- |
| 2023-09-15 |
Menold Daniel |
Vice President, Finance |
期权行权（卖出） |
15,000 |
$1.72 |
$25.8K |
- |
| 2023-09-13 |
Avoro Capital Advisors Llc |
10 Percent Owner |
知情卖出 |
250 |
$17.00 |
$4.25K |
250 |
| 2023-09-12 |
Avoro Capital Advisors Llc |
10 Percent Owner |
知情卖出 |
300 |
$17.00 |
$5.1K |
300 |
| 2023-08-18 |
Mcwherter Charles |
President of R&d |
期权行权（卖出） |
236 |
$5.00 |
$1.18K |
942 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
